Beyond tumor mutation burden: tumor neoantigen burden as a superior prognostic biomarker in resected gastric cancer

IntroductionGastric cancer is one of the most diagnosed cancers and a major contributor to cancer-related death in China. Recent studies have demonstrated the failure of tumor mutational burden (TMB) in predictive accuracy. Here, we aimed to evaluate the prognostic value of tumor neoantigen burden (...

Description complète

Détails bibliographiques

Auteurs principaux:	Tingting Lu, Jingyi Cao, Peng Liu, Xiaoxin Pan, Yiming Shen, Jian Wang, Zhida Chen, Yi Liu, Fenglin Zhang, Haiya Zhang, Gan Zhang, Yi Wang, Ji Wan, Hongqing Xi
Format:	Artigo
Langue:	Inglês
Publié:	Frontiers Media S.A. 2026-01-01
Collection:	Frontiers in Immunology
Sujets:	gastric cancer prognosis next-generation sequencing tumor neoantigen burden tumor mutation burden
Accès en ligne:	https://www.frontiersin.org/articles/10.3389/fimmu.2025.1722895/full
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!